NCT07524088 Contamination of Young Children Hair During Acute Cannabis Intoxication
| NCT ID | NCT07524088 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Toulouse |
| Condition | Cannabis Intoxication in Children |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2026-07-31 |
| Primary Completion | 2028-02-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2026-07-31 with a primary completion date of 2028-02-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hair analysis in pediatric cannabis intoxication is limited by possible sudoral self-contamination, especially in young children due to hair porosity. However, adult studies show no THC-COOH in sweat, challenging this hypothesis. THC-COOH presence in sweat has to this day never been studied in young children. Its absence would help assess the reliability of hair testing for prior exposure. Thus, our main objective is to describe whether THC-COOH can be detected in sweat following cannabis intoxication using gold standard techniques.
Eligibility Criteria
Inclusion Criteria: * Child admitted to the Specialized Emergency Pole (POSU) and pediatric medico-surgical emergencies for acute cannabis intoxication. * Child older than 3 months and younger than 3 years. * Holders of parental authority, affiliated with or beneficiaries of a social security system. Exclusion Criteria: * History of cannabis intoxication identified during the interview and/or consultation of the medical record. * Contraindication to sweat sampling (described in section 6). * Absence of hair and/or hair length \< 1 cm at the time of inclusion. * Ongoing breastfeeding (exclusive and mixed). * Inability to provide study-related informations to the holders of parental authority.
Contact & Investigator
Thomas Lanot
PRINCIPAL INVESTIGATOR
University Hospital of Toulouse
Frequently Asked Questions
Who can join the NCT07524088 clinical trial?
This trial is open to participants of all sexes, aged 3 Months or older, up to 3 Years, studying Cannabis Intoxication in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07524088 currently recruiting?
Yes, NCT07524088 is actively recruiting participants. Contact the research team at algans.n@chu-toulouse.fr for enrollment information.
Where is the NCT07524088 trial being conducted?
This trial is being conducted at Toulouse, France.
Who is sponsoring the NCT07524088 clinical trial?
NCT07524088 is sponsored by University Hospital, Toulouse. The principal investigator is Thomas Lanot at University Hospital of Toulouse. The trial plans to enroll 15 participants.